Approval · Notice of Compliance 8179 · 2006
MICRO MN: Notice of Compliance 8179
Issued July 28, 2006
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 8179
- Date
- July 28, 2006
- Company
- Sandoz Canada Inc.Saint-Hubert, Quebec, Canada
- Product type
- Nonprescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Trace element
Products in this notice
Medicinal ingredients
- MANGANESE SULFATE 0.1 MG per ML
- MANGANESE SULFATE 0.5 MG per ML